BACTERIAL MENINGITIS

 

BACTERIAL MENINGITIS

 

DEFINITION:

Inflammation of the meninges that is identified by an abnormal number of white blood cells (WBCs) in the cerebral spinal fluid (CSF) and evidence of a bacterial pathogen in the CSF.

EPIDEMIOLOGY:

  • incidence:
    • newborn: 0.5/1000 live births
    • childhood: ?
  • age of onset:
    • highest age-specific attack rates are in the newborn period and between 3-8 months of age
    • 90% of all cases before the age of 5 years
  • risk factors:

    1. Newborn

    • sepsis with hematogenous spread to meninges:
      • incidence of bacterial meningitis is about 1/4 cases of sepsis
      • blood usually invaded from a colonized site - respiratory tract or umbilical cord
    • rarely contamination from neural tube defects, congenital sinus tracts, penetrating scalp wounds

    2. Genetic

    • Inuit, Navajo, Alaskan Eskimos
    • HLA-B12, absence of Bw40
    • M > F

    3. Environment

    • closed communities - households, day-care centres, classrooms, institutions

    4. Host Factors

    • congenital/acquired deficiencies in host defense mechanisms:

    1. Antibody Deficiencies

    • subclasses of IgG

    2. Complement Deficiencies

    • C5 -> C8

    3. Splenic Deficiencies

    • following splenectomy
    • congenital asplenia or splenosis

    4. Others

    • sickle cell anemia & other hemoglobinopathies
    • malignancies

CLINICAL FEATURES:

1. Neonates and Young Infants

  • minimal and subtle (high index of suspicion)
  • fever (50%)
  • seizure (40%)
  • bulging fontanelle (33%)
  • irritable +/- change in consciousness & poor muscle tone (33%)
  • others:
    • apnea and bradycardia, cyanosis, diarrhea, disinterest in feeding, jaundice, lethargy, respiratory distress, temperature instability (hypothermia or fever), vomiting

2. Children

1. Symptoms

1. Classical

  • fever, headache, photophobia

2. Others

  • irritability, lethargy, mental confusion, nausea and vomiting
  • change in affect or state of alertness

2. Signs

1. Classical

  • Kernig and Brudzinski signs

2. Others

1. Skin

  • erythematous maculopapular rash -> purpura and petechiae (Neisseria)
  • Tache Cerebrale - stroke skin with a blunt instrument -> 30-60 sec -> raised red rash

2. Central Nervous System

  • seizures (20-30% of cases):
    • focal, generalized, or subtle, febrile
    • due to abscess, cerebritis, SIADH, subdural effusion, vascular thrombosis, ventriculitis
  • focal neurologic signs:
    • cranial nerve +/- facial palsies
    • hemiparesis, quadriparesis
  • visual signs:
    • endophthalmitis, papilledema
    • visual field defects (due to cortical venous or arterial thrombosis)
  • auditory signs:
    • ataxia & hearing loss (due to labyrinthitis)
  • altered state of consciousness:
    • obtunded, semicomatose, comatose

3. Systemic Conditions

  • cellulitis, septic arthritis, otitis media, pneumonia, etc which act as the source of infection

INVESTIGATIONS:

1. Lumbar Puncture (LP)

1. Indications

  • high index of suspicion (only 10-16% of LP's are positive)
  • any patient with sepsis or bacteremia
  • repeat LP within hours to days if clinical signs and symptoms persist
  • +/- febrile seizures (although only 5% have underlying meningitis)

2. Contraindications

  • cardiorespiratory compromise
  • increased intracranial pressure (ICP)
  • infection in the area of needle insertion
  • bleeding diathesis

3. Adverse Reactions

  • bleeding into CSF, headache, herniation of brainstem and cerebellar tonsils, pain

4. CSF Analysis (in patients >6 weeks of age)*

1. Normal

  • <5 WBC/uL
  • <40 mg/dl protein
  • 2.5-3.6 mmol/L glucose (<67%)

2. Bacterial

  • 200-2000 WBC/uL (PMN)
  • >130 mg/dl protein
  • <2.5 mmol/L glucose (<67%)

3. Viral

  • 0-200 WBC/uL (LYM)
  • <40 mg/dl protein
  • 2.5-3.6 mmol/L glucose (<67%)

4. Tumor

  • 0-200 WBC/uL (LYM)
  • 50-500 mg/dl protein
  • 2.5-3.6 mmol/L glucose (<67%)

 

  • *Bonadia, W.A. (1992), Pediatric Infectious Disease J. 11: 423-432
  • *FN rates can be as high as 47% but there appears to be a less than 1% chance that a patient with meningitis will have a completely normal CSF exam, ie., have to look at everything
  • risk factors for bacterial meningitis:
    • Pleocytosis
    • ANC >1 neutrophil/uL (with neutrophil predominance)
    • Hypoglycorrhachia (with a CSF:serum ratio <0.4)
    • Elevated CSF [Protein]
    • Positive Gram stain
  • CSF collection:
    • Tube #1 - cell count with differential - looking for pleocytosis and ANC
    • Tube #2 - glucose - looking for hypoglycorrhachia
    • Tube #2 - protein - looking for elevated [protein]
    • Tube #3 - gram stain, C&S - looking for organisms
    • Tube #4 - viral cultures - looking for virus

5. Pleocytosis (WBC Count)

1. Normal

  • Normal CSF WBC Count (WBC/uL):
    • Term - 8.2 (mean); 22 (upper limit of normal [+2SD])
    • 0-4 weeks - 11.0 (mean); 35 (upper limit of normal [+2SD])
    • 4-8 weeks - 7.1 (mean); 25 (upper limit of normal [+2SD])
    • >6 weeks - 2.3 (mean); 5 (upper limit of normal [+2SD])
  • CSF mean total WBC count is inversely proportional to patient age

2. Abnormal

  • vast majority of paediatric patients with bacterial meningitis are associated with CSF pleocytosis:
    • 0-4 weeks - 83% of cases
    • >4 weeks - 98% of cases
    • school-age - 100% of cases
  • CSF becomes opalescent when there are between 200-500 WBC/uL
  • magnitude depends upon invading organism:
    • N. meningitidis - 5476 (WBC/uL)
    • H. influenzae b - 4612 (WBC/uL)
    • S. pneumoniae - 1136 (WBC/uL)
  • time coure:
    • slight pleocytosis may persist 18-36 hours after initiating antibiotic therapy
    • significant reduction in WBC count within 48-72 hours after initiating antibiotic therapy
    • there may be a persistence of pleocytosis after the full antibiotic course

6. CSF Absolute Neutrophil Count (Neutrophils/uL)

1. Normal

  • ANC = total WBC count x % neutrophils x 0.01
  • normal CSF = <1 neutrophil/uL
  • normal % CSF neutrophils = <35% (in those <4 weeks)

2. Abnormal

  • abnormal CSF = >1 neutrophil/uL
  • CSF neutrophil (>50%) predominance in patients with bacterial meningitis:
    • 0 to 4 weeks of age - 100% of cases
    • >4 weeks of age - 99% of cases
  • no difference in CSF mean % neutrophil count associated with the 3 major pathogens (>3 months)

7. Hypoglycorrhachia

1. Normal

  • Normal Values of CSF Glucose (mmol/L):
    • Term - 2.9 (mean); 1.9-6.6 (range)
    • 0-4 weeks - 2.6 (mean); 2.0-3.4 (range)
    • 4-8 weeks - 2.6 (mean); 1.6-3.4 (range)
    • >6 weeks - 3.4 (mean); 2.5-3.6 (range)
  • CSF glucose characteristics:
    • derived from serum via a carrier-facilitated transport of glucose into the CSF
    • removed by bulk flow into the venous circulation and through utilization as a fuel source
    • CSF [glucose] usually < serum [glucose]
    • reaches adult CSF values by 4-8 weeks of life

2. Abnormal

  • majority of paediatric patients with bacterial meningitis are associated with hypoglycorrhachia:
    • 0-4 weeks - 61% of cases
    • >4 weeks - 78% of cases
    • school-age - 45% of cases
  • CSF glucose ranges from 1.1-1.7 mmol/L in the majority of cases of hypoglycorrhachia
  • mechanisms of hypoglycorrhachia:
    • increased rate of transport out of CSF
    • increased glycolysis by WBC and bacteria
    • increased metabolic rate of brain and spinal cord
    • decreased transport of glucose into the CSF due to inhibition of the membrane carrier system
  • in 70% of cases, the hypoglycorrhachia resolves after 48 hours of antibiotic therapy
  • CSF:serum glucose concentration ratio:
    • value of <0.4 is highly accurate in defining hypoglycorrhachia in bacterial meningitis
  • in children with bacterial meningitis >2 months, hypoglycorrhachia is 80% sensitive and 98% specific
  • may range from .2-.52 after complete course of antibiotics

8. Gram Stain

  • reveals bacteria in more than 90% of cases except in older (school-age) children where the rate of positive Gram stain is only 50%
  • rate of positive Gram stain is not associated with different pathogens
  • after 24-48 hours of adequate antibiotic therapy, 98% of cases convert to no organisms visualized on repeat CSF sampling
  • Neisseria and Listeria are most apt to be missed

9. Elevated CSF Protein Concentration

1. Normal

  • Normal Values of CSF Protein (mg/dl):
    • Term - 90 (mean); 20-170 (range)
    • 0-4 weeks - 84 (mean); 35-189 (range)
    • 4-8 weeks - 59 (mean); 19-121 (range)
    • >6 weeks - 28 (mean); 20-45 (range)
  • CSF protein content is age-dependent being greatest at birth because of increased permeability of the blood-brain barrier to protein at this time
  • two main components of CSF protein are albumin (70%) and gamma-globulin (10-15%) with an overall albumin:globulin ratio of about 5:1
  • very low CSF/serum protein ratio due to:
    • exclusion of high molecular weight proteins from the CSF
    • protein exit rate from CSF is 200-300x greater than the entrance rate into the CSF

2. Abnormal

  • majority of paediatric patients with bacterial meningitis are associated with elevated CSF [protein]:
    • 0-4 weeks of age - 55% of cases
    • >4 weeks of age - 93% of cases
    • school-age - 60% of cases
  • elevated CSF protein in bacterial meningitis usually ranges from 130-300 mg/dl but can reach levels 500-1000 mg/dl (14%) and >1000 mg/dl (8% of cases)
  • usually elevated within 16-18 hours after bacterial invasion
  • mechanisms of elevated CSF [Protein]:
    • opening of tight junctions of cerebral capillaries during the inflammatory process
    • complement and antibodies enter the CSF with other serum proteins
  • after appropriate antibiotic therapy, the CSF protein concentration may decrease by 75% from initial values
  • an abnormally low CSF [protein] (<20 mg/dl) may occur with conditions in which there is an elevated ICP (increases bulk flow reabsorption of protein out of the CSF)

10. Other

1. CSF Lactate Concentration

  • normally 14 mg/dl
  • in bacterial meningitis is usually <25 mg/dl

2. Intracranial Pressure

  • elevated in bacterial meningitis particularly during the first two days of illness

2. Serum

1. Gram Stain

  • positive in 85% of patients with GBS meningitis
  • positive in 75% of patients with gram negative meningitis

2. Blood Cultures

  • 70-85% of neonates with meningitis will have positive blood culture

3. Complete Blood Count

  • sepsis (leukocytosis)

3. Imaging Studies

1. CT/Ultrasound (for complications)

  • brain abscesses
  • subdural effusions or empyemas
  • ventriculitis
  • hydrocephalus

MANAGEMENT:

1. Antibiotic Therapy

1. Neonate (0-1 month)

  • empiric Ampicillin and Gentamicin

1. GBS

  • Ampicillin or Penicillin for 14-21 days

2. E. coli

  • Gentamicin +/- Cefotaxime for 21 days

3. Listeria monocytogenes

  • Ampicillin and Gentamicin for 14-21 days
  • resistant to all cephalosporins

4. Others covered

  • Enterococcus sp., Klebsiella pneumoniae, Salmonella sp.

2. Infant (1-3 months)

  • empiric Ampicillin and Cefotaxime

3. Infant (older than 3 months)

  • empiric Cefotaxime

1. H. influenzae

  • 50% of isolates Ampicillin resistant
  • treatment for 7-10 days

2. N. meningitids

  • penicillin resistant strains appearing
  • treatment for 7 days

3. S. pneumoniae

  • 5-15% of isolates Penicillin resistant
  • treatment for 7-10 days

2. Steriod Therapy

  • use in patients older than 6 weeks of age
  • give prior to first dose of antibiotic
  • dexamethasone 0.6 mg/kg/day IV q6h for 4 days
  • reduces incidence of neurologic sequelae, i.e., hearing loss

3. Supportive

  • sepsis +/- complications
  • elevated ICP
  • seizures
  • electrolyte abnormalities - SIADH

 

 

 

 

Pediatric Database - BACTERIAL MENINGITIS

Pediatric Organization - Pedbase [at] Gmail.com